Tilt Biotherapeutics Ltd.
Clinical trials sponsored by Tilt Biotherapeutics Ltd., explained in plain language.
-
Virus and supercharged immune cells attack tough melanoma
Disease control OngoingThis early-stage study is testing a new combination treatment for advanced melanoma that has not responded to other therapies. It uses a modified virus designed to infect and kill cancer cells, combined with the patient's own tumor-fighting immune cells and a short course of chem…
Phase: PHASE1 • Sponsor: TILT Biotherapeutics Ltd. • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
Virus therapy tested as new weapon against tough lung cancers
Disease control OngoingThis early-stage study is testing the safety of a new two-part treatment for advanced non-small cell lung cancer that has stopped responding to standard immunotherapy. The treatment combines a modified virus designed to attack tumors with an existing immunotherapy drug (pembroliz…
Phase: PHASE1 • Sponsor: TILT Biotherapeutics Ltd. • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC